Moorestown, New Jersey, United States

7322321334

seeking biotech alpha

seeking biotech alpha 寻求生物技术阿尔法 4/7/2020 the heart of biotech™

seeking biotech alpha 寻求生物技术阿尔法 4/7/2020 the heart of biotech™

seeking biotech alpha 寻求生物技术阿尔法 4/7/2020 the heart of biotech™ seeking biotech alpha 寻求生物技术阿尔法 4/7/2020 the heart of biotech™

38th Annual J.P. Morgan Healthcare Conference Slideshows

ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD)

image341

  

ACADIA Pharmaceuticals (ACAD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:06 PM ET|3 comments | About: ACADIA Pharmaceuticals Inc. (ACAD) ) 

Amgen Inc. (AMGN)

ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Inc. (ACAD)

image342

 

Amgen (AMGN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:13 PM ET | About: Amgen Inc. (AMGN) 

EXACT Sciences Corporation (EXAS)

ACADIA Pharmaceuticals Inc. (ACAD)

EXACT Sciences Corporation (EXAS)

image343

  

Exact Sciences (EXAS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:51 PM ET  | About: Exact Sciences Corporation (EXAS) 



Moderna, Inc. (MRNA)

Alexion Pharmaceuticals, Inc. (ALXN)

EXACT Sciences Corporation (EXAS)

image344

 

Moderna (MRNA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 3:27 PM ET|3 comments  | About: Moderna, Inc. (MRNA) 

Alexion Pharmaceuticals, Inc. (ALXN)

Alexion Pharmaceuticals, Inc. (ALXN)

Alexion Pharmaceuticals, Inc. (ALXN)

image345

 

Alexion Pharmaceuticals (ALXN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 3:27 PM ET | About: Alexion Pharmaceuticals, Inc. (ALXN) 

Insulet Corporation (PODD)

Alexion Pharmaceuticals, Inc. (ALXN)

Alexion Pharmaceuticals, Inc. (ALXN)

image346

 

Insulet Corporation (PODD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 1:45 PM ET | About: Insulet Corporation (PODD) 

38th Annual J.P. Morgan Healthcare Conference Slideshows

Amarin Corporation plc (AMRN)

BriaCell Therapeutics Corp. (BCTXF)

BriaCell Therapeutics Corp. (BCTXF)

 

Amarin (AMRN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 9:31 AM ET | About: Amarin Corporation plc (AMRN) 

BriaCell Therapeutics Corp. (BCTXF)

BriaCell Therapeutics Corp. (BCTXF)

BriaCell Therapeutics Corp. (BCTXF)

image347

 

BriaCell Therapeutics (BCTXF) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 3:11 PM ET | About: BriaCell Therapeutics Corp. (BCTXF) 

Editas Medicine, Inc. (EDIT)

BriaCell Therapeutics Corp. (BCTXF)

Stemline Therapeutics, Inc. (STML)

image348

 

Editas Medicine (EDIT) Investor Presentation - Slideshow

Jan. 16, 2020 2:00 PM ET  | About: Editas Medicine, Inc. (EDIT)
 

Stemline Therapeutics, Inc. (STML)

Stemline Therapeutics, Inc. (STML)

Stemline Therapeutics, Inc. (STML)

image349

 

Stemline Therapeutics (STML) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:59 PM ET  | About: Stemline Therapeutics, Inc. (STML) 

BeiGene, Ltd. (BGNE)

Stemline Therapeutics, Inc. (STML)

Agilent Technologies, Inc. (A)

 

Beigene (BGNE) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:53 PM ET | About: BeiGene, Ltd. (BGNE) 

Agilent Technologies, Inc. (A)

Stemline Therapeutics, Inc. (STML)

Agilent Technologies, Inc. (A)

image350

 

Agilent Technologies (A) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:10 PM ET | About: Agilent Technologies, Inc. (A) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

CVS Health Corporation (CVS)

Karuna Therapeutics, Inc. (KRTX)

CVS Health Corporation (CVS)

image351

 

CVS Health Corporation (CVS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 12:57 PM ET|7 comments | About: CVS Health Corporation (CVS) 

ImmunoGen, Inc. (IMGN)

Karuna Therapeutics, Inc. (KRTX)

CVS Health Corporation (CVS)

image352

 

ImmunoGen (IMGN) Investor Presentation - Slideshow

Jan. 16, 2020 1:30 PM ET | About: ImmunoGen, Inc. (IMGN) 

Karuna Therapeutics, Inc. (KRTX)

Karuna Therapeutics, Inc. (KRTX)

Karuna Therapeutics, Inc. (KRTX)

image353

 

Karuna Therapeutics (KRTX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 11:16 AM ET | About: Karuna Therapeutics, Inc. (KRTX) 

ABIOMED, Inc. (ABMD)

Boston Scientific Corporation (BSX)

Karuna Therapeutics, Inc. (KRTX)

image354

 

Abiomed (ABMD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 11:07 AM ET | About: Abiomed, Inc. (ABMD) 

Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX)

image355

 

Boston Scientific (BSX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:05 PM ET  | About: Boston Scientific Corporation (BSX)  

Becton, Dickinson and Company (BDX)

Boston Scientific Corporation (BSX)

Boston Scientific Corporation (BSX)

image356

 

Becton Dickinson (BDX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:09 PM ET  | About: Becton, Dickinson and Company (BDX) 

image357

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: Where Will The Top 10 Cities Be in 2035?


 

Top 10 Cities by Projected GDP


 

Top 10 Cities by Future Population

 

 

Top 10 Cities By Estimated Annual GDP Growth


 https://www.visualcapitalist.com/top-10-cities/ 

Mapped: The World’s Top 10 Cities in 2035Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019

By


 

https://www.visualcapitalist.com/top-10-cities/ 


 

Weighing The Week Ahead: Earnings Season Opportunities

Oct. 20, 2019 6:55 AM ET|28 comments  | Includes: BAPR, BAUG, BIBL, BJUL, BJUN, BOCT, CHGX, CRF, DDM, DIA, DMRL, DOG, DUSA, DXD, EDOW, EEH, EPS, EQL, EQWL, ESGL, FEX, FWDD, GSEW, HUSV, IVV, IWL, IWM, JHML, JKD, OMFS, OTPIX, PAPR, PAUG, PJAN, PJUN, PMOM, PPLC, PSQ, QID, QLD, QQEW, QQQ, QQQE, QQXT, RSP, RVRS, RWL, RWM, RWSL, RYARX, RYRSX, SCAP, SCHX, SDOW, SDS, SFLA, SFY, SH, SMLL, SPDN, SPLX, SPSM, SPUU, SPXE, SPXL, SPXN, SPXS, SPXT, SPXU, SPXV, SPY, SQQQ, SRTY, SSO, SSPY, SYE, TNA, TQQQ, TRND, TWM, TZA, UAUG, UDOW, UDPIX, UJAN, UOCT, UPRO, URTY, USA, USMC, UWM, VFINX, VOO, VTWO, VV, ZFJeff MillerValue, Growth 


 https://seekingalpha.com/article/4297479-weighing-week-ahead-earnings-season-opportunities 

2019 Q3 - Results

Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals, Inc. (ICPT)

image358

 

Intercept Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 11:26 AM ET | About: Intercept Pharmaceuticals, Inc. (ICPT) 

Neurocrine Biosciences, Inc. (NBIX)

Intercept Pharmaceuticals, Inc. (ICPT)

Intercept Pharmaceuticals, Inc. (ICPT)

image359

 

Neurocrine Biosciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 7:48 AM ET | About: Neurocrine Biosciences, Inc. (NBIX) 

: Amarin Corporation plc (AMRN)

Intercept Pharmaceuticals, Inc. (ICPT)

Becton, Dickinson and Company (BDX)

image360

 

Amarin Corporation plc 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET  | About: Amarin Corporation plc (AMRN) 

Becton, Dickinson and Company (BDX)

Becton, Dickinson and Company (BDX)

Becton, Dickinson and Company (BDX)

image361

 

Becton, Dickinson and Company 2019 Q4 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET|1 comment | About: Becton, Dickinson and Company (BDX) 

QIAGEN N.V. (QGEN)

Becton, Dickinson and Company (BDX)

IN.PACT™ Admiral™ DCB

image362

 

QIAGEN N.V. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 2:28 PM ET | About: QIAGEN N.V. (QGEN) 

IN.PACT™ Admiral™ DCB

Becton, Dickinson and Company (BDX)

IN.PACT™ Admiral™ DCB

image363

 

Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT™ Admiral™ DCB

Tue November 5, 2019 1:15 PM|GlobeNewswire|About: MDT

Longest-Term Data from a Real-World PAD Patient Population Presented at VIVA

DUBLIN and LAS VEGAS, Nov. 05, 2019 (GLOBE NEWSWIRE) --  Medtronic plc (MDT)

2019 Q3 - Results

Celgene Corporation (CELG)

Celgene Corporation (CELG)

Celgene Corporation (CELG)

image364

 

Celgene Corporation 2019 Q3 - Results - Earnings Call Presentation

Nov. 1, 2019 11:58 AM ET|5 comments | About: Celgene Corporation (CELG) 

Exelixis, Inc. (EXEL)

Celgene Corporation (CELG)

Celgene Corporation (CELG)

image365

 

Exelixis, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 3:51 PM ET|1 comment | About: Exelixis, Inc. (EXEL) 

Sanofi (SNY)

Celgene Corporation (CELG)

bluebird bio, Inc. (BLUE)

image366

 

Sanofi 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 1:57 PM ET | About: Sanofi (SNY) 

bluebird bio, Inc. (BLUE)

Vertex Pharmaceuticals Incorporated (VRTX)

bluebird bio, Inc. (BLUE)

 

bluebird bio (BLUE) Investor Presentation - Slideshow

Nov. 2, 2019 2:03 PM ET|1 comment | About: bluebird bio, Inc. (BLUE) 

GlaxoSmithKline plc (GSK)

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

image367

 

GlaxoSmithKline plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 30, 2019 10:13 AM ET | About: GlaxoSmithKline plc (GSK) 

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

image368

 

Vertex Pharmaceuticals Incorporated 2019 Q3 - Results - Earnings Call Presentation

Nov. 3, 2019 10:53 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

2019 Q3 - Results

Merck & Co., Inc. (MRK)

Incyte Corporation (INCY)

Merck & Co., Inc. (MRK)

image369

 

Merck & Co., Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:34 AM ET | About: Merck & Co., Inc. (MRK) 



Pfizer Inc. (PFE)

Incyte Corporation (INCY)

Merck & Co., Inc. (MRK)

image370

 

Pfizer Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 7:26 AM ET  | About: Pfizer Inc. (PFE) 



Incyte Corporation (INCY)

Incyte Corporation (INCY)

Incyte Corporation (INCY)

 

Incyte Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 9:32 AM ET | About: Incyte Corporation (INCY) 



Amgen Inc. (AMGN)

Seattle Genetics, Inc. (SGEN)

Incyte Corporation (INCY)

image371

 

Amgen Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 4:59 PM ET | About: Amgen Inc. (AMGN) 

NovoCure Limited (NVCR)

Seattle Genetics, Inc. (SGEN)

Seattle Genetics, Inc. (SGEN)

image372

NovoCure Limited 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 12:28 PM ET  | About: NovoCure Limited (NVCR) 

Seattle Genetics, Inc. (SGEN)

Seattle Genetics, Inc. (SGEN)

Seattle Genetics, Inc. (SGEN)

image373

 

Seattle Genetics, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:04 PM ET | About: Seattle Genetics, Inc. (SGEN) 

2019 Q3 - Results

Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO)

image374

 

Thermo Fisher Scientific Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 9:57 AM ET | About: Thermo Fisher Scientific Inc. (TMO) 

Novartis AG (NVS)

Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO)

image375

 

Novartis AG 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 6:53 AM ET | About: Novartis AG (NVS) 

Amarin Corporation plc (AMRN)

Thermo Fisher Scientific Inc. (TMO)

Amarin Corporation plc (AMRN)

image376

 

Amarin Corporation (AMRN) Investor Presentation - Slideshow

Oct. 3, 2019 10:59 AM ET|11 comments  | About: Amarin Corporation plc (AMRN) 

AstraZeneca PLC (AZN)

Gilead Sciences, Inc. (GILD)

Amarin Corporation plc (AMRN)

image377

 

AstraZeneca PLC 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 10:19 AM ET | About: AstraZeneca PLC (AZN) 



Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (GILD)

image378

 

Gilead Sciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 4:31 PM ET|1 comment  | About: Gilead Sciences, Inc. (GILD) 

Illumina, Inc. (ILMN)

Gilead Sciences, Inc. (GILD)

Gilead Sciences, Inc. (GILD)

image379

 

Illumina, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 6:25 PM ET|2 comments | About: Illumina, Inc. (ILMN) 

2019 Q3 - Results

Boston Scientific Corporation (BSX)

About: Alexion Pharmaceuticals, Inc. (ALXN)

Boston Scientific Corporation (BSX)

image380

 

Boston Scientific Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 8:21 AM ET | About: Boston Scientific Corporation (BSX) 

Alkermes plc (ALKS)

About: Alexion Pharmaceuticals, Inc. (ALXN)

Boston Scientific Corporation (BSX)

image381

 

Alkermes plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 7:57 AM ET | About: Alkermes plc (ALKS) 

About: Alexion Pharmaceuticals, Inc. (ALXN)

About: Alexion Pharmaceuticals, Inc. (ALXN)

About: Alexion Pharmaceuticals, Inc. (ALXN)

image382

 

Alexion Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 9:59 AM ET | About: Alexion Pharmaceuticals, Inc. (ALXN) 

Veracyte, Inc. (VCYT)

Eli Lilly and Company (LLY)

About: Alexion Pharmaceuticals, Inc. (ALXN)

image383

 

Veracyte, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 12:37 AM ET | About: Veracyte, Inc. (VCYT) 

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

image384

  

Eli Lilly and Company 2019 Q4 - Results - Earnings Call Presentation

Jan. 30, 2020 10:25 AM ET | About: Eli Lilly and Company (LLY) 


Biogen Inc. (BIIB)

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

image385

 

Biogen Inc. 2019 Q4 - Results - Earnings Call Presentation

Jan. 30, 2020 7:56 AM ET|1 comment | About: Biogen Inc. (BIIB)  

BAC Global HealthCare Conference & ESMO Congress 2019

Incyte Corporation (INCY)

Incyte Corporation (INCY)

Incyte Corporation (INCY)

image386

 

Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch Global Healthcare Conference - Slideshow

Sep. 19, 2019 10:11 AM ET | About: Incyte Corporation (INCY) 

About: Amgen Inc. (AMGN)

Incyte Corporation (INCY)

Incyte Corporation (INCY)

image387

 

Amgen Inc. (AMGN) Management Presents at The Bank of America Merrill Lynch Global Healthcare Conference (Transcript)

Sep. 18, 2019 9:01 AM ET | About: Amgen Inc. (AMGN) 

Amgen Inc. (AMGN)

Incyte Corporation (INCY)

: Novartis AG (NVS)

image388

 

Amgen (AMGN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:20 PM ET | About: Amgen Inc. (AMGN) 

: Novartis AG (NVS)

Bristol-Myers Squibb Company (BMY)

: Novartis AG (NVS)

image389

 

Novartis AG (NVS) Updates on Kisqali® MONALEESA-3 ESMO Data - Slideshow

Oct. 1, 2019 1:15 PM ET | About: Novartis AG (NVS) 

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

image390

Bristol-Myers Squibb (BMY) Presents At ESMO Congress 2019 - Slideshow

Sep. 30, 2019 3:34 PM ET | About: Bristol-Myers Squibb Company (BMY) 

AstraZeneca PLC (AZN)

Bristol-Myers Squibb Company (BMY)

Bristol-Myers Squibb Company (BMY)

image391

 

AstraZeneca Group (AZN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:06 PM ET | About: AstraZeneca PLC (AZN) 

Wainwright 21st Annual Global Investment Conference

CytoDyn (CYDY)

GW Pharmaceuticals plc (GWPH)

Sesen Bio, Inc. (SESN)

image392

 

CytoDyn (CYDY) Investor Presentation - Slideshow

Sep. 16, 2019 12:51 PM ET | About: CytoDyn Inc. (CYDY) 

Sesen Bio, Inc. (SESN)

GW Pharmaceuticals plc (GWPH)

Sesen Bio, Inc. (SESN)

image393

 

Sesen Bio (SESN) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow

Sep. 16, 2019 1:51 PM ET | About: Sesen Bio, Inc. (SESN) 

GW Pharmaceuticals plc (GWPH)

GW Pharmaceuticals plc (GWPH)

ProBeam 360 Proton Therapy System

image394

 

GW Pharmaceuticals (GWPH) Investor Presentation - Slideshow

Sep. 16, 2019 1:53 PM ET | About: GW Pharmaceuticals plc (GWPH) 

ProBeam 360 Proton Therapy System

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

ProBeam 360 Proton Therapy System

image395

 

Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

Mon September 16, 2019 8:00 AM|PR Newswire|About: VAR

PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (VSEA) (NYSE: VAR)

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

image396

 

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia

Mon September 16, 2019 6:30 AM|GlobeNewswire|About: BCTXF, INCY, MRK

BERKELEY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTXF) ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF)

VCF Care Pathway

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

image397

 

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)

Mon September 16, 2019 10:00 AM|GlobeNewswire|About: MDTGlobeNewswire

DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (MDT)

earnings Call Slides Q2./HY 2019

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

image398

 

Novo Nordisk A/S 2019 Q2 - Results - Earnings Call Slides

Aug. 14, 2019 3:43 PM ET | About: Novo Nordisk A/S (NVO) 

Insulet Corporation (PODD)

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

image399

 

Insulet (PODD) Presents At Canaccord Genuity Growth Conference - Slideshow

Aug. 13, 2019 2:31 PM ET | About: Insulet Corporation (PODD) 

China Biologic Products Holdings, Inc. (CBPO)

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

China Biologic Products Holdings, Inc. (CBPO)

image400

 

China Biologic Products Holdings, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 7, 2019 12:12 PM ET | About: China Biologic Products Holdings, Inc. (CBPO) .

CRISPR Therapeutics AG (CRSP)

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

China Biologic Products Holdings, Inc. (CBPO)

 

CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow

Aug. 13, 2019 2:26 PM ET|2 comments  | About: CRISPR Therapeutics AG (CRSP) 

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

image401

 

Sangamo Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 13, 2019 1:47 PM ET | About: Sangamo Therapeutics, Inc. (SGMO) 

EPS of $-0.25 beats by $0.04 Revenue of $35.99M (-20.52% Y/Y) beats by $6.37M

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

image402

 

Intrexon Corporation 2019 Q2 - Results - Earnings Call Slides

Aug. 9, 2019 6:29 PM ET | About: Intrexon Corporation (XON) 

earnings Call Slides Q2./HY 2019

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

image403

 

Celgene Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 1:34 PM ET | About: Celgene Corporation (CELG) 

Amarin Corporation plc (AMRN)

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

 

Amarin Corporation plc 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 10:18 AM ET  | About: Amarin Corporation plc (AMRN) 

EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M

image404

 

Veracyte, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 3:06 PM ET | About: Veracyte, Inc. (VCYT) 

Abiomed, Inc. (ABMD)

Vertex Pharmaceuticals Incorporated (VRTX)

EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M

 

Abiomed, Inc. 2020 Q1 - Results - Earnings Call Slides

Aug. 1, 2019 10:03 AM ET | About: Abiomed, Inc. (ABMD) 

Becton, Dickinson and Company (BDX)

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

image405

 

Becton, Dickinson and Company 2019 Q3 - Results - Earnings Call Slides

Aug. 6, 2019 10:16 AM ET | About: Becton, Dickinson and Company (BDX) 

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals Incorporated (VRTX)

image406

 

Vertex Pharmaceuticals Incorporated 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 4:58 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

earnings Call Slides Q2./HY 2019

Incyte Corporation (INCY)

Bayer Aktiengesellschaft (BAYZF)

Incyte Corporation (INCY)

image407

 Incyte Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:26 AM ET  | About: Incyte Corporation (INCY) 

Merck & Co., Inc. (MRK)

Bayer Aktiengesellschaft (BAYZF)

Incyte Corporation (INCY)

image408

 Merck & Co., Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:14 AM ET|1 comment | About: Merck & Co., Inc. (MRK) 

Bayer Aktiengesellschaft (BAYZF)

Bayer Aktiengesellschaft (BAYZF)

Bayer Aktiengesellschaft (BAYZF)

image409

 Bayer Aktiengesellschaft 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 6:39 AM ET | About: Bayer Aktiengesellschaft (BAYZF) 

Amgen Inc. (AMGN)

Neurocrine Biosciences, Inc. (NBIX)

Bayer Aktiengesellschaft (BAYZF)

image410

 Amgen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:25 PM ET | About: Amgen Inc. (AMGN) 



 http://investors.amgen.com/static-files/e1393dc2-f372-4dcc-992a-afc36a03b8fa 

Gilead Sciences, Inc. (GILD)

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences, Inc. (NBIX)

image411

 Gilead Sciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 4:57 PM ET|2 comments | About: Gilead Sciences, Inc. (GILD) 

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences, Inc. (NBIX)

image412

Neurocrine Biosciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 2:37 PM ET|1 comment | About: Neurocrine Biosciences, Inc. (NBIX) 

earnings Call Slides Q2./HY 2019

Pfizer Inc. (PFE)

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

image413

 Pfizer Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 12:06 PM ET | About: Pfizer Inc. (PFE) 

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

image414

 Sanofi 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 10:04 AM ET | About: Sanofi (SNY) 

EPS of $9.15 beats by $1.62 Revenue of $3.62B (7.75% Y/Y) beats by $142.47M

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

EPS of $9.15 beats by $1.62 Revenue of $3.62B (7.75% Y/Y) beats by $142.47M

image415

 Biogen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 23, 2019 12:39 PM ET|1 comment | About: Biogen Inc. (BIIB) 

Exact Sciences Corporation (EXAS)

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

EPS of $9.15 beats by $1.62 Revenue of $3.62B (7.75% Y/Y) beats by $142.47M

image416

 Exact Sciences Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 2:01 PM ET | About: Exact Sciences Corporation (EXAS) 

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

image417

 Illumina, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:07 AM ET | About: Illumina, Inc. (ILMN) 

Eli Lilly and Company (LLY)

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

image418

 Eli Lilly and Company 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:15 AM ET | About: Eli Lilly and Company (LLY) 

earnings Call Slides Q2./HY 2019

EPS of $0.365 beats by $0.06 Revenue of $5.82B (12.96% Y/Y) beats by $251.68M

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

image419

 

AstraZeneca PLC 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 10:01 AM ET | About: AstraZeneca PLC (AZN) 

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

image420

 

Seattle Genetics, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 17, 2019 1:58 PM ET  | About: Seattle Genetics, Inc. (SGEN) 

EPS of $1.32 beats by $0.19 Revenue of $825.8M (16.46% Y/Y) beats by $63.51M

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

EPS of $1.32 beats by $0.19 Revenue of $825.8M (16.46% Y/Y) beats by $63.51M

image421

 

Varian Medical Systems, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 2:07 PM ET | About: Varian Medical Systems, Inc. (VAR) 

NovoCure Limited (NVCR)

Roche Holding AG (RHHBY)

EPS of $1.32 beats by $0.19 Revenue of $825.8M (16.46% Y/Y) beats by $63.51M

image422

  

NovoCure Limited 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 11:37 AM ET | About: NovoCure Limited (NVCR) 

Alkermes plc (ALKS)

Roche Holding AG (RHHBY)

Roche Holding AG (RHHBY)

image423

 

Alkermes plc 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:19 AM ET | About: Alkermes plc (ALKS) 

Roche Holding AG (RHHBY)

Roche Holding AG (RHHBY)

Roche Holding AG (RHHBY)

image424

 

Roche Holding AG 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:17 AM ET  | About: Roche Holding AG (RHHBY) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN)

image425

 Regeneron Pharmaceuticals (REGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 2:57 PM ET | About: Regeneron Pharmaceuticals, Inc. (REGN) 

Celgene Corporation (CELG)

Regeneron Pharmaceuticals, Inc. (REGN)

Regeneron Pharmaceuticals, Inc. (REGN)

image426

 Celgene (CELG) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:43 PM ET | About: Celgene Corporation (CELG) 

Amgen Inc. (AMGN)

Regeneron Pharmaceuticals, Inc. (REGN)

BioMarin Pharmaceutical Inc. (BMRN)

image427

 Amgen (AMGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 11:42 AM ET  | About: Amgen Inc. (AMGN) 

BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Inc. (BMRN)

image428

 BioMarin Pharmaceutical (BMRN) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:45 PM ET  | About: BioMarin Pharmaceutical Inc. (BMRN) 

Illumina, Inc. (ILMN)

BioMarin Pharmaceutical Inc. (BMRN)

Illumina, Inc. (ILMN)

image429

 Illumina, Inc. (ILMN) Presents at J.P. Morgan Healthcare Conference - Slide Show

Jan. 7, 2019 8:10 PM ET|9 comments  | About: Illumina, Inc. (ILMN) 

Allergan plc (AGN)

BioMarin Pharmaceutical Inc. (BMRN)

Illumina, Inc. (ILMN)

 Allergan (AGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 1:19 PM ET|2 comments | About: Allergan plc (AGN) 

©2018 MarketsandMarkets Research Private Ltd.

Biomarker Technologies Market

Biomarker Technologies Market

Biomarker Technologies Market

image430

 Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022

Efficacy Testing Market

Biomarker Technologies Market

Biomarker Technologies Market

image431

 Efficacy Testing Market by Product and Service (Consumables, Services), Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) - Global Forecast to 2022

Oncology Nutrition Market

Biomarker Technologies Market

Oncology Information System Market

image432

 Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023

Oncology Information System Market

Non Invasive Prenatal Testing (NIPT) Market

Oncology Information System Market

image433

 Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019

Non Invasive Prenatal Testing (NIPT) Market

Non Invasive Prenatal Testing (NIPT) Market

Non Invasive Prenatal Testing (NIPT) Market

image434

 Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

Bioinformatics Market

Non Invasive Prenatal Testing (NIPT) Market

Non Invasive Prenatal Testing (NIPT) Market

image435

 Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023

©2018 BlackRock, Inc. All Rights Reserved.

image436

Sep 25, 2018 By Bob Miller, Rick Rieder

 An exceptionally strong labor market and reasonably firm inflation
have the Fed monitoring the heat in the U.S. economy. 


image437

  September 2018 - 

BlackRock Investment Institute 

We see a growing disconnect between waning market attention to our top 10 geopolitical risks and the likelihood of some of them escalating. Our global BlackRock Geopolitical Risk Indicator (BGRI) has declined since our last update, suggesting the market’s attention to geopolitical risks overall has edged down. Yet the overall reading masks considerable dispersion, and we have raised the likelihood of three of our risks.Global trade tensions is our focus risk this month as U.S. trade disputes with major trading partners carry on. 

image438

 Sep 19, 2018 -  By Russ Koesterich 

 At $3.5 trillion per year, total healthcare spending (public and private) makes up roughly 20% of the U.S. economy. The nation’s 80 million baby boomers provide a stable source of ongoing revenue growth for healthcare companies throughout the value chain. Demographic tailwinds are widely expected to continue to propel this secular story in the United States. 

image439

 Sep 14, 2018 By Michael Fredericks

 In the United States, we continue to observe above-trend fundamental data, including strong corporate earnings, capital expenditures (business investment) and consumer sentiment. U.S. stocks notably outperformed international markets, with the S&P 500 Index rallying over 3% in August whereas European equities, for instance, were negative. We believe U.S. outperformance will likely persist in the near-term, underscoring our preference for more domestic-oriented assets. 

image440

 Oct 1, 2018

By BlackRock Investment Institute

 We see the steady global expansion rolling on, underpinned by above-trend U.S. growth. Yet the range of potential economic outcomes is widening. Gradual increases in U.S. rates are tightening financial conditions globally, and have contributed to bouts of volatility and sharply depreciating emerging market (EM) currencies. We also take a deep dive into the prospects for EMs after an unexpectedly drawn-out selloff. 

image441

 Oct 8, 2018 By Richard Turnill

 Global equities’ nearly decade-long bull run is stoking anxiety about its ability to power on. One concern: narrow breadth — a fragile state when a small group of stocks is contributing the lion’s share of market returns, buoying the broader index. We see today’s strong equity performance, especially in the U.S., as broad-based and driven by healthy fundamentals and solid earnings momentum. 

© 2018 Grand View Research, Inc. All rights reserved.

image442

 Posted On Sep, 05, 2018

Cancer Biomarkers Market: Increasing demand for rapid and specific cancer diagnosis

 

image443

Posted On Sep, 05, 2018 

Regenerative Medicine: Presence of strong product pipeline coupled with emerging applications in gene therapy projected to drive market


image445

Posted On Sep, 05, 2018

 Biosimilars - A Pioneering Approach To Futuristic Treatments!


image446

   June 2018 

The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period.

image447

 Published Date: Sep, 2018

Metagenomics Market Size, Share & Trends Analysis Report By Product (Sequencing & Data Analytics), By Technology (Sequencing, Function), By Application (Environmental), And Segment Forecasts, 2018 - 2025

Some of the prominent players operating in this market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup.